Introduction
Neuronal nicotinic acetylcholine receptors (nAChR) have a pivotal role in modulating the release of various neurotransmitters from different brain areas including the hippocampus and the striatum (for review see Wonnacott, 1997, Vizi and Kiss, 1998) . The hippocampus is a key structure implicated in memory formation where changes in long term synaptic potentiation are considered to be a cellular mechanism underlying aspects of learning and memory. Nicotinic agonists, through activation of neuronal nAChR, improve cognitive performance in both animals and humans (Levin and Simon, 1998; Newhouse et al., 2004) , and hippocampal nAChR, including α 7 nAChR influence synaptic plasticity through facilitation of presynaptic and postsynaptic mechanisms (Ji et al., 2001) . Furthermore, Alzheimer's disease patients exhibit memory deficits characterized by a marked decline in cholinergic transmission and a decreased number of nAChR binding sites in the cortex and hippocampus (Gotti and Clementi, 2004) , and nicotine can ameliorate the cognitive deficit in these patients (Newhouse et al., 2004) . Therefore, the modulatory properties of nAChR contribute to both normal and pathological brain functions.
The noradrenergic input to the hippocampus largely arises from the ascending dorsal noradrenergic bundle that projects from the locus coeruleus (Ungerstedt, 1971) . In vivo, intra-hippocampal administration of nicotine evoked noradrenaline (NA) release in a mecamylamine-sensitive manner (Mitchell, 1993) . The presence of presynaptic nAChR on noradrenergic terminals in the hippocampus is consistent with nicotine-evoked [ 3 H]NA release from hippocampal synaptosomes (Clarke and Reuben, 1996; Luo et al., 1998) .
Pharmacological studies to characterise the nAChR mediating [ 3 H]NA release from hippocampal synaptosomes and slices provided evidence for nAChR heterogeneity, but the paucity of specific antagonists has limited the resolution of the subtypes of nAChR involved (Clarke and Reuben, 1996; Sershen et al., 1997; Anderson et al., 2000; see Vizi and Kiss, 1998) . Luo et al. (1998) (Risso et al., 2004) , and there is a large body of evidence from electrophysiological recordings from hippocampus that α 7 nAChR regulate both glutamatergic and GABAergic neurotransmission (e.g. Gray et al., 1996; McQuiston and Madison, 1999; Alkondon and Albuquerque, 2000a; Buhler and Dunwiddie, 2001) . Hence, α 7 nAChR are a plausible candidate for an indirect modulation of NA release.
In the present work, we have examined the role of α 7 nAChR in the modulation of This article has not been copyedited and formatted. The final version may differ from this version. (Anderson et al., 2000; Jacobs et al., 2002 
Chronic nicotine administration Rats were anaesthetized with Isofluorane and Alzet
Osmotic minipumps (model 2002) were implanted subcutaneously; osmotic minipumps were filled with saline (control) or nicotine bitartrate, dissolved in saline and pH adjusted to 7.4, to deliver nicotine (4 mg/kg/day, free base) at a rate of 0.5 µl/h for 14 days. Nicotine administration was without effect on weight gain. To study the withdrawal period, osmotic minipumps were surgically removed after 14 days and animals were sacrificed by cervical dislocation and decapitation 3 or 7 days later. Each timepoint was determined for at least 8 rats, with saline-and nicotine-treated animals paired.
Nicotine and cotinine levels Following decapitation, trunk blood was collected in heparinised Eppendorf tubes. Blood was centrifuged at 2500 rpm for 15 min at 4°C, the supernatant was collected and re-centrifuged at 1500 rpm for 30 min at 4°C; the final supernatant was frozen in liquid nitrogen and stored until submitted for nicotine and cotinine analysis. Following 14 days of nicotine administration, nicotine and cotinine levels were 49.8 ± 3.0 ng/ml and 335.3 ± 18.2 ng/ml respectively (n=16). was determined in the presence of 1 mM nicotine. Samples were incubated for 1.5 h at room temperature, followed by 30 min at 4 o C. Then samples were filtered through Gelman GFA filters, presoaked overnight in 0.3% polyethylene immine (PEI) using a Brandel cell harvester. Filters were washed 3 times with ice cold PBS, and counted for radioactivity using a Packard 1600 Tricarb scintillation counter (counting efficiency 45%). Each assay was conducted in triplicate. 10 Stat, Jandel scientific, Ekhrath, Germany). Values of at least p<0.05 were taken to be statistically significant.
Radioligand binding Membrane preparation
Dose response curves for agonists (except choline) were fitted to a single-or double-site model as previously described by Kaiser and Wonnacott (2000) . The choline dose response curve was fitted to a bell-shaped model as described by:
where, Y is the amount [
Results

Specificity of [
3 H]NA uptake by hippocampal slices. The hippocampus receives modest dopaminergic projections from the midbrain (Jay et al., 2003) and nAChR activation has been shown to modulate DA release from hippocampal slices (Cao et al., 2004 into rat frontal cortical synaptosomes (Cheetham et al., 1996) , the amount of Consistent with data from hippocampal synaptosomes (Luo et al., 1998) Mogg et al., 2002) . Pre-incubation of hippocampal slices with 20 nM MLA had no effect on responses to 1 µM AnTx (Fig. 1C) . However MLA and the structurally unrelated To confirm the involvement of α 7 nAChR, we used the selective agonist choline (Alkondon et al., 1997 1A) with a bell-shaped concentration response curve. The maximum response in hippocampal slices was reached by 5 mM choline and corresponds to 33.3 ± 1.4 % of that achieved by AnTx. In both tissues, choline-evoked responses were nAChR-mediated as they were fully abolished by mecamylamine (20 µM) (Fig. 1A, B Pittaluga and Raiteri (1992) (Fig. 2B ).
Responses elicited by glutamate (100 and 500 µM), AMPA (100 and 500 µM) and kainate (100 and 500 µM) were largely abolished by the selective AMPA/Kainate antagonist DNQX (200 µM, Fig. 2A value of 33.0 µM, consistent with previous studies (Pittaluga and Raiteri, 1992, Risso et al., 2004 ; Fig. 2A ). The specific NMDA antagonist MK801 (5 µM) fully blocked the response to 500 µM NMDA ( Fig. 2A) . Antagonists had no effect on basal release in the absence of agonists.
To explore possible crosstalk between glutamate receptors (GluR) and nAChR, we determined the AnTx concentration response curve for [ (Fassio et al., 1999) . In the hippocampal slice preparation, GABA (100 µM) induced a fractional release of subtype. Muscimol (100 µM), a GABA A receptor agonist, mimicked the response to GABA and this release was also completely blocked by bicuculline (Fig. 3A) . On the other hand, the GABA B -selective agonist, baclofen (100 µM), was ineffective (Fig. 3A) . treatment with nicotine, but was significantly up-regulated by 61.6 ± 19.4 % at 3 days withdrawal (Fig. 4B ). This functional up-regulation returned to control levels at 7 days withdrawal.
Inhibition of choline-evoked [ 3 H]NA release by DNQX or bicuculline was similar at the 3 time points (Table 3) , indicating a lack of effect of the nicotine treatment at non-NMDA GluR and GABA A receptors. This is consistent with the lack of change in AMPA-and GABA-evoked (Table 4) .
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Subtypes of nAChR mediating [ 3 H]NA release from hippocampal slices.
Pharmacological identification of nAChR subtypes mediating NA release has been restricted by the limited availability of drugs to discriminate different combinations of nAChR subunits. 18 see Kaiser and Wonnacott, 2000) . The ineffectiveness of α -CnTxMII with respect to AnTx- (Fig. 1B) or nicotine-evoked [ 3 H]NA release from hippocampal preparations (Luo et al., 1998) rules out α 6(α3)β2* nAChR, whereas partial inhibition by α -CnTxAuIB (Luo et al., 1998) supports the presence of α 3β4* nAChR. However these results do not exclude the possibility of an α 6(α3)β4* combination (see Léna et al., 1999) . were partially blocked by antagonists of both NMDA and non-NMDA GlutR (Fig. 2 Pittaluga and Raiteri, 1992) .
This article has not been copyedited and formatted. The final version may differ from this version. represent 10-15% of the total neuronal population in the hippocampus, predominantly located in the stratum oriens and stratum radiatum (Freund and Buzsáki, 1996) . GABAergic interneurons are heterogeneous with respect to their nAChR complement: (i) >50% express exclusively α 7 nAChR, (ii) ~30% express a combination of both α 7 and non-α7 nAChR and (iii) the remainder give no response to nicotine (Alkondon and Albuquerque, 2000a; McQuiston and Madison, 1999; Buhler and Dunwiddie, 2001 ). Activation of nAChR on interneurons induces the release of GABA (Kofalvi et al., 2000) that, depending on the GABAergic innervation, can strongly inhibit pyramidal cells (Freund and Buzsáki, 1996) or inhibit another interneuron, resulting in disinhibition of pyramidal cells (McQuiston and Madison, 1999; Ji and Dani, 2000; Bulher and Dunwiddie, 2001 ). This process of disinhibition has also been described for cerebral cortical interneurons (Alkondon et al., 2000b) .
The abolition of GABAergic component is present in the hippocampal preparation, conferring a more complex picture of neurotransmitter crosstalk (Fig. 5 ).
Physiological implications of α 7 nAChR modulation of NA release
Physiologically, the endogenous activation of α 7 nAChR arises from the substantial cholinergic input to the hippocampus from the medial septum diagonal band complex of the basal forebrain that targets mainly GABAergic interneurons (Frotscher and Leranth, 1985) .
Because the cholinergic varicosities exhibit sparse synaptic contacts (~10-20%), interneuronal communication is likely to reflect volume transmission. Depending on the frequency of activation of the cholinergic fibres, the concentration of ACh (or its degradation product choline) might be sufficient to activate α 7 nAChR, or to desensitise them. The
GABAergic interneurons participate in the maintenance of rhythmic activities that include a nicotinic component in their modulation (Cobb et al., 1999) , therefore imbalance in the regulation of excitation/inhibition could alter hippocampal functions. For example, we showed This article has not been copyedited and formatted. The final version may differ from this version. (Cho et al., 2005) . Interestingly, chronic infusion for 10 days with higher doses of nicotine caused an increase in nicotine- (Grilli et al., 2005) , AMPA-and NMDA-evoked [ 3 H]NA release (Risso et al., 2004) . In contrast, Jacobs et al. (2002) reported that repeated nicotine injections led to a decrease in nicotine-evoked (Done et al., 1992; Grasing et al., 1997) . Moreover, a sustained elevation of NA, but not DA, in the brains of mice during withdrawal from nicotine delivered in the drinking water has been reported (Gaddnas et al., 2000) . Thus the interplay of transmitter systems shown in the present study to mediate the nicotinic modulation of NA release in the hippocampus could contribute to altered noradrenergic function during nicotine withdrawal.
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Figures legends
32
The noradrenergic varicosity bears glutamate, GABA A and non-α7 nicotinic heteroreceptors. α 7 nAChR are proposed to reside on glutamate afferents and a population of GABAergic interneurons (Alkondon et al., 2000a; Fabian-Fine et al., 2001 This article has not been copyedited and formatted. The final version may differ from this version. 
